Microembolic Signals and Aspirin Resistance in Patients with Carotid Stenosis.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 234, doi. 10.1111/j.1755-5922.2010.00259.x
- By:
- Publication type:
- Article
Works matching IS 17555914 AND DT 2012 AND VI 30 AND IP 4
Results: 14
1
2
Effects of Beta-Blockade on Exercise Performance at High Altitude: A Randomized, Placebo-Controlled Trial Comparing the Efficacy of Nebivolol versus Carvedilol in Healthy Subjects.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 240, doi. 10.1111/j.1755-5922.2011.00261.x
- By:
- Publication type:
- Article
3
Matricellular Proteins: New Molecular Targets To Prevent Heart Failure.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e198, doi. 10.1111/j.1755-5922.2011.00276.x
- By:
- Publication type:
- Article
4
Imidazoline Antihypertensive Drugs: Selective I<sub>1</sub>-Imidazoline Receptors Activation.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 209, doi. 10.1111/j.1755-5922.2011.00269.x
- By:
- Publication type:
- Article
5
Blood Pressure in Renal Disease: How to Accomplish the Goal?
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 193, doi. 10.1111/j.1755-5922.2010.00260.x
- By:
- Publication type:
- Article
6
Pharmacological Properties of the Central Antihypertensive Agent, Moxonidine.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 199, doi. 10.1111/j.1755-5922.2011.00268.x
- By:
- Publication type:
- Article
7
TRITON and Beyond: New Insights into the Profile of Prasugrel.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e174, doi. 10.1111/j.1755-5922.2011.00263.x
- By:
- Publication type:
- Article
8
Targeting Inflammation in Cardiovascular Diseases. Still a Neglected field?
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e189, doi. 10.1111/j.1755-5922.2011.00274.x
- By:
- Publication type:
- Article
9
Novel Platelet ADP P2Y12 Inhibitors in the Treatment of Acute Coronary Syndrome.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e167, doi. 10.1111/j.1755-5922.2011.00262.x
- By:
- Publication type:
- Article
10
Metabolic Antianginal Agent Ranolazine Offers Good Symptom Relief in a Patient with Inoperable Severe Aortic Stenosis.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e210, doi. 10.1111/j.1755-5922.2011.00273.x
- By:
- Publication type:
- Article
11
Why Do Homocysteine-Lowering B Vitamin and Antioxidant E Vitamin Supplementations Appear To Be Ineffective in the Prevention of Cardiovascular Diseases?
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 227, doi. 10.1111/j.1755-5922.2011.00266.x
- By:
- Publication type:
- Article
12
Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 217, doi. 10.1111/j.1755-5922.2011.00277.x
- By:
- Publication type:
- Article
13
Ginsenoside Re: Pharmacological Effects on Cardiovascular System.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e183, doi. 10.1111/j.1755-5922.2011.00271.x
- By:
- Publication type:
- Article
14
Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 249, doi. 10.1111/j.1755-5922.2011.00264.x
- By:
- Publication type:
- Article